Adipokines in obesity and metabolic-related-diseases

被引:36
作者
Pestel, Julien [1 ]
Blangero, Ferdinand [1 ]
Watson, Julia [1 ]
Pirola, Luciano [1 ]
Eljaafari, Assia [1 ,2 ,3 ]
机构
[1] Univ Claude Bernard Lyon 1, INSERM U1060 CarMeN, Lab CarMeN, INRAE,CHLS, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[2] Hosp Civils Lyon, 2 Quai Celestins, F-69001 Lyon, France
[3] Ctr Hosp Lyon Sud, Lab CarMeN, INSERM U 1060 CarMeN, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
关键词
Adipokine; Obesity; White adipose tissue; brown adipose tissue; cells; Adipocytes; In flammatory disease; Adipose tissue-derived mesenchymal stem; BROWN ADIPOSE-TISSUE; TUMOR-NECROSIS-FACTOR; HIGH-MOLECULAR-WEIGHT; FACTOR-KAPPA-B; ACTIVATED PROTEIN-KINASE; CORONARY-ARTERY-DISEASE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; TNF-ALPHA; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.biochi.2023.04.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of leptin in the 1990s led to a reconsideration of adipose tissue (AT) as not only a fatty acid storage organ, but also a proper endocrine tissue. AT is indeed capable of secreting bioactive molecules called adipokines for white AT or batokines for brown/beige AT, which allow communication with numerous organs, especially brain, heart, liver, pancreas, and/or the vascular system. Adipokines exert pro or anti-inflammatory activities. An equilibrated balance between these two sets ensures homeostasis of numerous tissues and organs. During the development of obesity, AT remodelling leads to an alteration of its endocrine activity, with increased secretion of pro-inflammatory adipokines relative to the anti-inflammatory ones, as shown in the graphical abstract. Pro-inflammatory adipokines take part in the initiation of local and systemic inflammation during obesity and contribute to comorbidities associated to obesity, as detailed in the present review. (c) 2023 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
引用
收藏
页码:48 / 59
页数:12
相关论文
共 50 条
[41]   Targeting Adipokines in Obesity-Related Tumors [J].
Pu, Xi ;
Chen, Deyu .
FRONTIERS IN ONCOLOGY, 2021, 11
[42]   Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases [J].
Pham, Duc-Vinh ;
Park, Pil-Hoon .
ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (10) :997-1016
[43]   Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease [J].
Roos, Cornelis J. ;
Quax, Paul H. A. ;
Jukema, J. Wouter .
BIOMARKERS IN MEDICINE, 2012, 6 (01) :35-52
[44]   MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases [J].
Hulsmans, Maarten ;
Holvoet, Paul .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (32) :5704-5717
[45]   Adipose tissue macrophage in obesity-associated metabolic diseases [J].
Yao, Jingfei ;
Wu, Dongmei ;
Qiu, Yifu .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[46]   Contribution of specific ceramides to obesity-associated metabolic diseases [J].
Hammerschmidt, Philipp ;
Bruening, Jens C. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (08)
[47]   Nutritional approaches for managing obesity-associated metabolic diseases [J].
Botchlett, Rachel ;
Woo, Shih-Lung ;
Liu, Mengyang ;
Pei, Ya ;
Guo, Xin ;
Li, Honggui ;
Wu, Chaodong .
JOURNAL OF ENDOCRINOLOGY, 2017, 233 (03) :R145-R171
[48]   Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway [J].
Murtaza, Munazza ;
Khan, Gulnaz ;
Aftab, Meha Fatima ;
Afridi, Shabbir Khan ;
Ghaffar, Safina ;
Ahmed, Ayaz ;
Hafizur, Rahman M. ;
Waraich, Rizwana Sanaullah .
PLOS ONE, 2017, 12 (06)
[49]   MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients [J].
Withers, Sarah B. ;
Dewhurst, Toni ;
Hammond, Chloe ;
Topham, Caroline H. .
NON-CODING RNA, 2020, 6 (01)
[50]   The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox [J].
Irene Karampela ;
Gerasimos Socrates Christodoulatos ;
Maria Dalamaga .
Current Obesity Reports, 2019, 8 :434-457